The t(8;21) translocation associated with acute myeloid leukemia (AML) disrupts two genes, the AML1 gene also known as the core binding factor A2 (CBFA2) on chromosome 21, and a gene on chromosome 8, hereafter referred to as MTG8, but also known as CDR and ETO. Extensive information is available on AML1, a member of the CBF family of transcription factors, containing a highly conserved domain, the runt box, of the Drosophila segmentation gene runt. This gene is essential for the hematopoietic development and is found disrupted in several leukemias. In contrast, the function of the MTG8 gene is poorly understood. The predicted protein sequence shows two unusual, putative zinc-®ngers, three proline-rich regions, a PEST domain and several phosphorylation sites. In addition, we found a region encompassing aa 443 ± 514 predicted to have a signi®cant propensity to form coiled coil structures. MTG8 displays a high degree of similarity with nervy, a homeotic target gene of Drosophila, expressed in the nervous system. Human and mouse wild-type MTG8 are also highly expressed in brain relative to other tissues. For these reasons, we set out to investigate the expression and subcellular localization of the MTG8 protein in neural cells. Immunohistochemical experiments in a 12.5-dayold mouse embryo clearly showed that the protein was expressed in the neural cells of the developing brain and the spinal cord. In primary cultures of hippocampal neurons of 2 ± 3 day-old mice, MTG8 was found in the nucleus, in the cytoplasm and as ®ne granules in the neurites. Cytoplasmic localization of the protein was observed in Purkinje cells of both human and mouse cerebellum. The molecular mass of MTG8 in total human and mouse brain was analysed by immunoblotting and determined to be between 70 and 90 kDa. Isoforms with the same molecular mass were demonstrated in synaptosomes isolated from mouse forebrain. The evidence of MTG8 in the nucleus and cytoplasm of neural cells suggests a speci®c mechanism regulating the subcellular localization of the protein.
Introduction
The (8;21) translocation associated with acute myeloid leukemia is one of the chromosome rearrangements involving the core binding factor (CBF), also known as the polyomavirus-enhancer-binding-protein 2 (PEBP2) (for reviews see Speck and Stacy, 1995; Nucifora and Rowley, 1995; Meyers and Hiebert, 1995; Ito, 1996) . CBF is a heterodimeric transcription factor composed of two subunits, a and b (Kagoshima et al., 1993) . The a subunit, with DNA binding properties, contains a region of homology with the runt gene of Drosophila (Daga et al., 1992) and the b subunit stabilizes the binding of the a subunit to DNA. Recent work has demonstrated that both subunits are essential for a correct hematopoiesis (Okuda et al., 1996; Wang et al., 1996a,b; Castilla et al., 1996; Sasaki et al., 1996; Yergeau et al., 1997; Niki et al., 1997) and that their disruption may be crucial for leukemogenesis. Other genes are found involved together with the CBF genes in dierent leukemia subtypes. Speci®cally, in the t(8;21) positive acute myelogenous leukemia, AML1 (Miyoshi et al., 1991) encoding for a CBFa subunit was found fused to an unknown gene on chromosome 8, independently isolated in dierent laboratories named ETO (Erickson et al., 1992) , CDR (Nisson et al., 1992) and MTG8 . A clue to the possible function of the gene came with the cloning of two full-length brain cDNAs, MTG8a and b, containing almost identical open reading frames (ORFs). Since our work is based on the information provided by these ORFs, hereafter we will use for this protein the designation MTG8. The predicted ORFs of MTG8a and b encode two proteins of 577 and 604 amino acids respectively. MTG8 contains a few relevant motifs suggesting a role as a transcription factor . MTG8 shows a high degree of sequence similarity to nervy, a homeotic target gene of Drosophila that is expressed in the nervous system (Feinstein et al., 1995) , it is a remarkably conserved between human and mouse (Erickson et al., 1994) and its expression seems to be very high in brain relative to other tissues . These overall observations point to a possible role of the wild-type MTG8 in the dierentiation/development of the neural system.
Analysis of the transcripts of t(8;21) leukemic cells demonstrated that MTG8 was fused either in-frame (Erickson et al., 1992; Nisson et al., 1992; Nucifora et al., 1993; Era et al., 1995a,b) or out-of-frame (Tighe and Calabi, 1994; van de Locht et al., 1994; Saunders et al., 1996) with the 5' region of AML1. Thus, in leukemic cells MTG8 is expressed as a part of the chimeric AML1/MTG8 protein(s). Chimeric proteins were detected in a t(8;21) positive cell line and patients' blasts (Sacchi et al., 1996; Erickson et al., 1996) . Since some t(8;21) negative leukemic cell types also express high levels of wild-type MTG8 transcripts Era et al., 1995a,b) we formerly suggested that the ectopic expression of MTG8 could have a role in leukemogenesis. Recently, it was shown that expression of MTG8 in NIH3T3 cells leads to foci of transformation and colony growth in soft agar, suggesting that MTG8 may have transforming properties when ectopically expressed at high level . On the other hand MTG8 has been observed in the CD34 enriched hematopoietic progenitor fraction mobilized to peripheral blood by growth factors (Erickson et al., 1996) , implying that a basal expression of MTG8 in hematopoietic cells is not by itself leukemogenic. To understand whether MTG8 plays a role in leukemogenesis, it is still necessary to clarify several issues including its normal function in cells and tissues that normally express the gene and the consequences of its overexpression in hematopoietic cells that normally express little or no MTG8.
In this study, we investigated the subcellular localization of MTG8 in neural cells, since MTG8 is expressed at high level in brain. In dierent mouse and human neural cells we found MTG8 localized both in the nucleus and the cytoplasm, suggesting a complex regulation of MTG8 in cells of the nervous system.
Results

Characterization of anti MTG8 antibodies
We raised three rabbit polyclonal antibodies, AB 1499, AB 2174 and AB 52, against two synthetic peptides based on the MTG8b aminoacid sequence. The same peptide was used to raise AB 1499 and AB 2174. The antibodies were characterized for their speci®city using both an in vitro and an in vivo expressed MTG8b protein.
The entire MTG8b open reading frame was cloned in a mammalian expression vector and used as a template for in vitro transcription and translation experiments and transient transfections of COS 7 cells. As can be seen in Figure 1a , lane 1 a few polypeptides were produced after in vitro transcription and translation of MTG8b. Both AB 1499 and AB 52 could immunoprecipitate the two largest in vitro translated proteins with a molecular mass between 70 and 90 kDa ( Figure 1a , lanes 2 and 4). The ®rst band is the full-length MTG8b protein and the second band is interpreted as a polypeptide containing both epitopes recognized by the two dierent antibodies, likely resulting from the translation of the ®rst ATG site downstream from the initiation codon. The lowest molecular weight bands that are not recognized by both antibodies are interpreted as shorter polypeptides deriving from premature stops. In parallel control immunoprecipitations using the corresponding preimmune sera, no protein could be identi®ed (lanes 3 and 5). COS 7 cells were transfected with a MTG8b construct and with a control construct containing the FMR1 gene (mock transfection). By Western blotting with AB 1499, we detected a band in the COS 7 cells transfected with MTG8b, but not in the mock transfected cells (Figure 1b In independent experiments using mouse and human brain, MTG8 can be visualized either as one thick band as in Figure 1 , very likely a doublet, or two distinct bands with similar molecular weight, probably representing the MTG8a and b products, respectively (see Figure 6 ).
Subcellular localization of MTG8
The speci®city of the antibodies for immunostaining cells and tissues was ®rst tested using as controls either the corresponding preimmune sera or antibodies pre adsorbed with the cognate peptides. The results of a typical preliminary experiment to test the speci®city of immunostaining are shown in Figure 2 . On sections of a 12.5-day-old mouse embryo we can see MTG8
expression in neural cells of the spinal cord detected by the primary antibody AB 52 (Figure 2A ), but not in the control ( Figure 2B ) where the same antibody was pre adsorbed with the cognate peptide. In analogous preliminary experiments we tested the speci®city of AB 1499 and AB 2174 (data not shown). The speci®city of the antibodies was also demonstrated in COS 7 cells transfected with MTG8 b. As can be seen in Figure 3A and D both AB 1499 (A) and AB 52 (D) reacted with the nuclei of those cells that were transfected with the MTG8b construct, but not with the nuclei of non transfected cells. While in the COS cells and in neural cells of developing mouse embryo MTG8 seems to be essentially nuclear, at a closer analysis of other mouse and human neural cells, the protein was also observed in the cytoplasm. In sections of human adult cerebellum we could detect in the molecular layer a few neurons with positive nuclei ( Figure 3E , AB 52), as well as Purkinje cells with remarkable expression in the cytoplasm and the dendrites ( Figure 3B , AB 1499). These observations were con®rmed by immunostaining sections of adult mouse cerebellum ( Figure 4A ) using AB 2174 (against the same peptide of AB 1499). In mouse cerebellum MTG8 is present also in the glomeruli, a region rich in synapses. The speci®city of the immunostaining was demonstrated by using the antibody pre adsorbed with the cognate peptide ( Figure 4B ).
In sections of 12.5-day-old mouse embryo, both antibodies strongly reacted with the nuclei of a great proportion of neural cells of the spinal cord ( Figure  3C , AB 1499 and F, AB 52) and developing brain (data not shown). In these sections we can see a remarkable expression of the protein, possibly also in the cytoplasm of these cells. This result suggests that the protein is highly expressed during neural development. In primary cultures of hippocampal neurons (8 days in culture) from 2 ± 3-day-old mouse, MTG8 was seen in the nucleus, in the perikaryon and in ®ne granules in the neurites ( Figure 5A , AB 1499), as previously observed in Purkinje cells ( Figure 5B , AB 1499).
Detection of MTG8 in synaptosomes
Detection of MTG8 in the glomeruli and in ®ne patches on the neurites (Figures 4 and 5) suggested us to biochemically analyse the synaptosomal fraction of mouse neural cells. We isolated synaptosomes from 20-day-old mouse forebrain. The puri®cation of synaptosomes was controlled by using synaptophysin as a marker. The presence of this synaptosomal protein was demonstrated by Western blotting using an antisynaptophysin antibody (Figure 6 , lane 4). In this Figure 4 Paran sections of adult mouse cerebellum immunostained (A) with AB 2174 and (B) the same antibody pre adsorbed with the corresponding peptide. MTG8 is observed in the cytoplasm and dendrites of Purkinje cells. Immunoreactivity is also present at the level of glomeruli Expression of MTG8 protein in neural cells N Sacchi et al fraction we could also detect FMR1, a protein known to be present at synaptic level (Tamanini et al., 1997) .
In the same fraction analysed with AB 1499 (Figure 6 , lane 3) we could detect the same MTG8 bands observed in total mouse brain ( Figure 6 , lane 2). These bands are not detected by the control preimmune serum (Figure 6 , lane 1). In independent Western blotting experiments, the two bands (Figure 6 , lane 5), interpreted as MTG8a and b respectively, were not detected by AB 1499 pre adsorbed with the corresponding peptide ( Figure 6 , lane 6).
Discussion
The preliminary steps to determine the physiological role of a gene isolated by positional cloning include the search of structural homologies with known sequenced genes, the analysis of the predicted protein structure and the detection of its normal tissue distribution. In the case of MTG8(CDR/ETO), identi®ed by the molecular analysis of the t(8;21) associated with acute myeloid leukemia, the predicted aminoacid sequence based on full-length cDNAs of two alternate transcripts isolated from human brain showed several noteworthy features. In particular, there was evidence of three regions rich in proline, noted in some transcription factors, a PEST region, for rapid intracellular degradation of the protein, two CysHis regions that are not conventional putative zinc ®nger motifs. The proline regions are also rich in serine and threonine, that are, very likely, phosphorylation sites . Moreover, a certain degree of similarity was observed between MTG8 and nervy, a homeotic target gene of Drosophila (Feinstein et al., 1995) whose expression is limited to the nervous system. Notably, the pattern of Cys-His residues is conserved in MTG8, nervy and RP-8 originally identi®ed as a protein that is induced in neurons upon programmed cell-death (Owens et al., 1991) . In addition, we found by analysis of the MTG8b protein sequence with the computer program Coils (Lupas et al., 1991) that the protein contains between aa 443 and 514 a region predicted to have a signi®cant propensity to form a coiled coil structure, thus suggesting that the protein may interact with other proteins that may determine its subcellular localization. Interestingly, this region is maintained in the chimeric AML1/MTG8 protein found in t(8;21) leukemic cells.
Brain is the organ with the highest level of MTG8 transcripts relative to other organs Erickson et al., 1994 Erickson et al., , 1996 . This remarkable expression, and the overall hints provided by the protein sequence and structure, suggest that MTG8 may have a regulatory function in the dierentiation/ development of the nervous system. For this reason we investigated more in detail the subcellular localization of the MTG8 protein in neural cells, performing the study at the protein level using anti-MTG8 antibodies against protein sequences conserved in human and mouse (Erickson et al., 1994) . While the MTG8 protein that is overexpressed in COS 7 cells and NIH3T3 ®broblasts is nuclear, we observed that in dierent neural cells MTG8 is localized either in the nucleus or in the cytoplasm, or both. Our data suggest that the intracellular localization of the protein is possibly spatially and temporally regulated. Immunohistochemical staining of sections of adult human and mouse cerebellum showed expression of MTG8 in the cytoplasm and the dendrites of Purkinje cells and in the nuclei of neurons of the molecular layer. Nuclear localization of MTG8 was associated with cells in the developing brain (data not shown) and the spinal cord in the 12.5-day-old mouse embryo. In primary cultures of hippocampal neurons of newborn mouse MTG8 is instead expressed both in the nucleus and the cytoplasm, including the neurites. Expression of the protein in the glomeruli of mouse cerebellum, a region rich in synapses and as ®ne patches on the denclaites of Purkinje cells, suggests that the protein may be also present at synaptic level. Interestingly, MTG8 could be detected biochemically in the synaptosomal fraction isolated from 20-day-old mouse forebrain, supporting the immunocitochemical observation of a cytoplasmic localization of the protein. This preliminary result also indicates that MTG8 may be part of the repertoire of proteins active at the synaptic level. Ultrastructural and functional studies are needed to clarify this question. How the subcellular distribution of MTG8 in dierent (neural) cells is regulated is currently unknown. Given the features and the motifs so far recognized in the protein sequence, both phosphorylation and protein-protein interactions may be possible mechanisms responsible for the subcellular localization of the protein. Moreover, how the intracellular distribution of MTG8 correlates with dierent neural cell types, with cellular proliferation, migration and dierentiation at speci®c stages of neural development remains to be investigated.
Improving our knowledge of the normal function of MTG8 in the nervous system can be relevant not only to understand its role in neural processes, but also to further elucidate the role of MTG8 as oncoprotein in myeloid cells. Recent data seem to indicate that the ectopic expression of MTG8 in NIH3T3 has transforming properties. It is therefore possible that the overexpression of MTG8 may contribute to the disruption of the myeloid differentiation program, becoming a contributing factor of leukemic transformation.
Materials and methods
Antibody preparation and characterization
Synthetic peptides prepared according to the MTG8b amino acid sequence were used to raise rabbit polyclonal antibodies by means of standard protocols (Harlow and Lane, 1988) . Two antibodies, AB 1499 and AB 2174 were raised against the peptide RQQSPVNPDPVALDAHREFLHRPASGYVP spanning aa 414 ± 442 and another antibody, AB 52, was raised against the peptide TPPAATPRSTTPGTPSTIE spanning aa 582 ± 604. These regions are conserved both in mouse and human (Erickson et al., 1994) .
The speci®city of the antibodies was tested with dierent methods. The MTG8b cDNA sequence corresponding to the ORF was cloned in a mammalian expression vector and used as a template in a TNT coupled Reticulocyte Lysate System (Promega, Madison, WI) in combination with SP6 RNA polymerase. The 35 S-methionine labeled MTG8b was immunoprecipitated with either 1006 diluted AB 1499 or Expression of MTG8 protein in neural cells N Sacchi et al 1006 diluted AB 52 in a 10 mM HEPES buer (pH 7.4) containing 300 mM KCl 2 , 5 mM MgCl 2 , 100 mM CaCl 2 , 0.45% TritonX-100, 0.05% Tween-20 for 2 h, incubated with protein A Sepharose beads (Pharmacia) for 1 h, washed ®ve times with the immunoprecipitation buer, eluted from the beads by boiling, resolved by SDS ± PAGE electrophoresis and visualized by¯uorography. Preimmune sera (1 : 100) were used as controls. MTG8b cDNA was also transfected in COS 7 cells using lipofectamine (Life Technologies). After 72 h the over expressed MTG8 protein was detected either by Western blot or immunocytochemistry using the anti-MTG8 antibodies.
Immunoblotting
Total protein extracts were prepared from cells and brain tissue. Tissues were homogenized at 10 mM HEPES buer (pH 7.4) containing 300 mM KCl 2 , 5 mM MgCl 2 , 100 mM CaCl 2 0.45% TritonX-100, 0.05% Tween-20, 1 mM phenylmethylsulphonyl¯uoride (PMSF) followed by sonication. Samples were boiled in a reducing sample buer (16buer: 60 mM Tris pH 6.8, 2.5% b-mercaptoethanol, 1% SDS, 5% glycerol, 0.01 bromophenol blue). After SDS ± PAGE gel electrophoresis and electroblotting, proteins were visualized using a 10006 diluted AB 1499 or AB 52 and a 40006 diluted secondary anti-rabbit antibody supplied in the ECL Western blotting analysis system (Amersham International) according to the manufacturer's protocol.
Immunohistochemistry
Human brain tissue (cerebellum) and mouse embryos were embedded in Tissue Tek (Miles) and snap frozen in liquid nitrogen. Cryostat sections were ®xed in 100 mM phosphate buer saline (PBS) pH 7.3, containing 4% paraformaldehyde for 10 min, followed by ®xation in 100% methanol for 20 min. Paran sections were prepared using brain obtained from deeply anesthetized adult mice intracardially perfused with 4% paraformaldehyde. Endogenous peroxidase was inhibited by 30 min incubation in PBS-hydrogen peroxide-sodium azide solution at r.t. according to Li et al. (1987) . Sections were incubated with AB 1499, AB 52 or preimmune control serum (1 : 100) for 1 h at r.t. followed by incubation with a peroxidase conjugated swine antirabbit secondary antibody (1 : 100) (Dako) or a biotinylated goat-antirabbit secondary antibody revealed according a protocol of the ABC Elite kit (Vector). Antigen-antibody complexes were visualized with 3,3'diaminobenzidine-tetrahydrochloride as a substrate (Dako). All sections, with the exception of the mouse adult cerebellum sections, were counter stained with hematoxylin. The same protocol was used for immunocytochemical staining of cultured neurons and COS 7 cells.
Primary cultures of neural cells
Hippocampi were dissected from 2-to 3-day-old mouse brain and placed in Hank's balanced salt solution without Ca 2+ and Mg 2+ (HBSS). The tissue was quickly cut into small pieces, incubated in 0.25% trypsin, 5 U/ml DNase for 10 min and mechanically dissociated in HBSS with 5 U/ml DNase. Divalent cations were restored by adding two volumes of HBSS with Ca 2+ and Mg 2+ . Non dispersed tissue was allowed to settle for 3 min and the supernatant containing mostly dispersed cells was centrifuged at 200 g for 1 min. Cells were seeded on glass coverslips coated with D-polylysine and cultured for 1 ± 2 weeks in Neurobasal medium supplemented with B-27 serum free supplement (Life Technologies) and 25 mM glutamic acid according to the manufacturer's protocol.
Synaptosomes puri®cation
Synaptosomes were prepared from the forebrain of 20-dayold mice following the protocol of Rao and Stewart (1991) . Brie¯y, a 20% (w/v) homogenate was prepared from chopped forebrain in 0.35 M sucrose, 10 mM Tris pH 7.4, 0.5 mM EGTA buer. The homogenate was centrifuged at 20 000 g in a JA-20 ®xed-angle rotor to remove the nuclear pellet. The supernatant was centrifuged at 23 000 g for 4 min to yield a crude mitochondrial pellet. This pellet was washed once in the same buer, centrifuged again at the same speed, resuspended in 6 ml buer and layered onto a discontinuous gradient 5 ± 13% Ficoll in 0.35 M sucrose. The gradient was centrifuged at 45 000 g for 45 min in SW50.1 rotor. The synaptosomal fraction was collected from the 5 ± 13% interface, diluted in 0.35 M sucrose and centrifuged at 23 000 g for 20 min. To con®rm the presence of synaptosomes in the ®nal pellet, synaptophysin a glycoprotein present in the membrane of the neurosecretory granules at the postsynaptic site was used as a marker. To demonstrate the presence of this marker in the isolated pellet a monoclonal antibody directed against synaptophysin (Sigma) was used at 1: 2000 dilution.
